Clinical trial NCT05171101: The MAVEN Senior Scientist Initiative
Official title: The MAVEN Senior Scientist Initiative: A Trial of an Educational Training Program to Accelerate Diversity in Health & Science Leadership
Study type: INTERVENTIONAL
Overall status: ENROLLING_BY_INVITATION
Phase: PHASE2
Conditions: Lack of Diversity in Scientific Leadership
Keywords: Science
Scientists
Leadership
Women
Minority
Diversity
Virtual
Educational
Mentoring
Lead sponsor: Northwell Health
Sponsor class: OTHER
Collaborators: name: National Institute of General Medical Sciences (NIGMS)
name: National Institutes of Health (NIH)
First posted: 2021-12-28
Enrollment: 160
Sex: ALL
Minimum age (years): 35
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Randomized Educational RCT
Primary purpose: OTHER

Brief summary: MAVEN is an education training program designed to expand the national pool of qualified women and minority candidates for senior scientist positions across all NIGMS areas of science. Senior scientists (N=160, N=40 per cohort) belonging to an ethnicity, race or gender under-represented at the senior levels of faculty will be enrolled in a randomized 2-arm trial to determine the effects of the MAVEN intervention (comprised of virtual educational sessions and ongoing mentorship) on the following outcomes: 1) increased career satisfaction (primary outcome); 2) peak academic productivity; 3) expanded scientific networks; and 4) leadership ascension.

Detailed description: The long-term objective of the MAVEN education training program is to expand the national pool of qualified women and minority candidates for senior scientist positions across all National Institute of General Medical Sciences (NIGMS) areas of science. The investigators intend to create a self-sustaining community committed to inclusive excellence in science. The investigators will do so by adapting best education practices from other industries in executive leadership, strategic career planning, and institution culture change, to create a sustainable, but intensive program with objective evaluation metrics. Using a randomized, 2-arm trial design, the investigators will enroll 40 senior scientists per year in 4 cohorts into the MAVEN study (160 participants total). Participants will be randomized to the MAVEN intervention group or the control group. Participants in the MAVEN group will receive two 7-day virtual institutes focused on senior scientist career planning, respect-based leadership, evidence-based mentoring, organizational culture problem solving, transparency and Open Science, interdisciplinary team collaboration and inclusivity, and effective science thought leadership. These summer institutes will be comprised of didactics, discussions, and interactive individual and team-based activities. Between the institutes there will be 10 months of mentorship, networking, and conduct of institutional change projects. Participants randomized to the control arm will complete all study measures but will not receive access to any of the virtual sessions or mentorship. Target program participants are scientists 10-15 years from their terminal degree , who identify as women, particularly as belonging to an ethnicity or race under-represented at the senior levels of faculty, and who currently hold one or more R01 or equivalent grants. To achieve the MAVEN long-term objective, scientists enrolled in the MAVEN intervention arm will be provided the skills to attain: 1) increased career satisfaction (primary outcome); 2) peak academic productivity; 3) expanded scientific networks; and 4) leadership ascension. Program success will be evaluated primarily by comparison of the control group to MAVEN scientists for change in career satisfaction scores, and also by a blended Major Educational Score Index comprised of h-index, relative citation ratio, number of publications in journals with an impact factor \> 5, and annual federal grant dollar amounts. The investigators will also explore changes to professional scientific network size and the leadership ascension between the two groups, tested quantitatively. Primary, secondary, and exploratory outcomes will be evaluated at baseline for each cohort and yearly for all cohorts until the cessation of the program. If the scientific leaders and role models are diverse, the investigators of the current trial stand to benefit from enrichment of the pool of future investigators, the broader perspective in research agenda prioritization, the greater success in recruiting diverse research participants, and the enhanced ability to advance science to reduce health disparities.

Eligibility criteria: Inclusion Criteria:

* Scientists 10 to 15 years from terminal degree in their field
* Identify as an ethnicity, race, or gender which is under-represented in senior levels of faculty.
* Have one or more funded R01 level grant (or equivalent level grant)

Exclusion Criteria:

* Scientists \<10 or \>15 years from terminal degree in their field
* Do not identify as an ethnicity, race, or gender which is under-represented in senior levels of faculty.
* Do not have one or more funded R01 level grant (or equivalent level grant)

Primary outcomes:
measure: Career Satisfaction
timeFrame: Assessed at baseline and yearly afterwards until study completion 5 years following enrollment of the first cohort..
Secondary outcomes:
measure: Academic Productivity
timeFrame: Assessed at baseline and yearly afterwards until study completion 5 years following enrollment of the first cohort.
Other outcomes:
measure: Professional Network Size
timeFrame: Assessed at baseline and yearly afterwards until study completion 5 years following enrollment of the first cohort.
measure: Scientific Leadership Ascension
timeFrame: Assessed at baseline and yearly afterwards until study completion 5 years following enrollment of the first cohort.
Locations:
city: New York
country: United States
facility: Institute of Health System Science
state: New York
Study officials:
affiliation: Northwell Health
name: Karina Davidson, PhD, MASc
role: PRINCIPAL_INVESTIGATOR
References: